Synthesis of a cyclic-thioether peptide which binds anti-cardiolipin antibodies
✍ Scribed by David S Jones; Christina A Gamino; Martina E Randow; Edward J Victoria; Lin Yu; Stephen M Coutts
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- French
- Weight
- 238 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
✦ Synopsis
Thioether cyclized peptide analogue, 1, was synthesized using solid phase FMOC chemistry on HMPB-MBHA resin, ct-Methylproline was introduced as an FMOC-alanyl-a-methylproline dipeptide, and the thioether was incorporated as FMOC-protected thioether tetrapeptide intermediate, 8. Compound 1 has been shown to bind anti-cardiolipin antibodies.
📜 SIMILAR VOLUMES
## Abstract ## Objective The evolution of the rheumatoid arthritis (RA)–specific anti–cyclic citrullinated peptide (anti‐CCP) antibody response, as measured by the isotypes of anti‐CCP, has not been described. This study was undertaken to determine anti‐CCP isotype usage in patients with undiffere
## Abstract ## Objective To examine the association between HLA–DRB1 alleles and the production of anti–cyclic citrullinated peptide (anti‐CCP) and rheumatoid factor (RF) autoantibodies in patients with rheumatoid arthritis (RA). ## Methods We studied 1,723 Caucasian RA patients enrolled in the
## Abstract The U1A (or nRNP A) protein is known to play a critical role in eukaryotic pre‐mRNA splicing and polyadenylation. Previous studies revealed that several mouse monoclonal antibodies (MAbs) recognized U1A as part of the U1snRNP, while MAb 12E12 was unique in that it recognized an epitope